1211 related articles for article (PubMed ID: 33178113)
1. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
Saeed U; Lang AE; Masellis M
Front Neurol; 2020; 11():572976. PubMed ID: 33178113
[TBL] [Abstract][Full Text] [Related]
2. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.
Saeed U; Compagnone J; Aviv RI; Strafella AP; Black SE; Lang AE; Masellis M
Transl Neurodegener; 2017; 6():8. PubMed ID: 28360997
[TBL] [Abstract][Full Text] [Related]
3. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.
Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J
Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877
[TBL] [Abstract][Full Text] [Related]
4. Neuroimaging in Parkinsonian Disorders.
Tripathi M; Kumar A; Bal C
Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
[TBL] [Abstract][Full Text] [Related]
5. Nuclear imaging in Parkinson's disease: The past, the present, and the future.
Golan H; Volkov O; Shalom E
J Neurol Sci; 2022 May; 436():120220. PubMed ID: 35313223
[TBL] [Abstract][Full Text] [Related]
6. Free-water imaging in Parkinson's disease and atypical parkinsonism.
Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
[TBL] [Abstract][Full Text] [Related]
7. Neuroimaging in Parkinson's Disease: necessity or exaggeration?
Śmiłowska K; Burzyńska-Makuch M; Brockhuis B; Piekarski R; Friedman A; Popek A; Sławek J
Neurol Neurochir Pol; 2021; 55(6):536-548. PubMed ID: 34637136
[TBL] [Abstract][Full Text] [Related]
8. Imaging neurodegeneration in Parkinson's disease.
Pavese N; Brooks DJ
Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in Parkinson's disease (recent update).
Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
[TBL] [Abstract][Full Text] [Related]
10. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.
Berardelli A; Wenning GK; Antonini A; Berg D; Bloem BR; Bonifati V; Brooks D; Burn DJ; Colosimo C; Fanciulli A; Ferreira J; Gasser T; Grandas F; Kanovsky P; Kostic V; Kulisevsky J; Oertel W; Poewe W; Reese JP; Relja M; Ruzicka E; Schrag A; Seppi K; Taba P; Vidailhet M
Eur J Neurol; 2013 Jan; 20(1):16-34. PubMed ID: 23279440
[TBL] [Abstract][Full Text] [Related]
11. Imaging in Parkinson's disease.
Pagano G; Niccolini F; Politis M
Clin Med (Lond); 2016 Aug; 16(4):371-5. PubMed ID: 27481384
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease: diagnosis.
Brooks DJ
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S31-3. PubMed ID: 22166447
[TBL] [Abstract][Full Text] [Related]
13. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
[TBL] [Abstract][Full Text] [Related]
15. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
[TBL] [Abstract][Full Text] [Related]
16. Role of Neuroimaging on Differentiation of Parkinson's Disease and Its Related Diseases.
Ogawa T; Fujii S; Kuya K; Kitao SI; Shinohara Y; Ishibashi M; Tanabe Y
Yonago Acta Med; 2018 Sep; 61(3):145-155. PubMed ID: 30275744
[TBL] [Abstract][Full Text] [Related]
17. Neuroimaging of Sleep Disturbances in Movement Disorders.
Yousaf T; Pagano G; Wilson H; Politis M
Front Neurol; 2018; 9():767. PubMed ID: 30323786
[TBL] [Abstract][Full Text] [Related]
18. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
Thobois S; Guillouet S; Broussolle E
Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging in Parkinson's disease.
Au WL; Adams JR; Troiano A; Stoessl AJ
J Neural Transm Suppl; 2006; (70):241-8. PubMed ID: 17017536
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging for Lewy body disease: is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?
Vernon AC; Ballard C; Modo M
Brain Res Rev; 2010 Oct; 65(1):28-55. PubMed ID: 20685363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
